Skip to main content

Advertisement

Table 3 Treatment summary

From: Long- term outcome of paediatric patients with ANCA vasculitis

Patient IV CP Oral CP IV MP OSt AZA/
MMF
Cy Biologic Agents PEX
1 + - - + + - - -
2 + + - + + + - -
3 + - + + + - Rituximab (x1) 9 cycles
4 - - - + + + - -
5 - +++ - + + + - -
6 + + + + + + Rituximab (x2)
Infliximab (x1)
Campath (x1)
-
7 + + + + + + Rituximab (x4) -
8 - ++ + + + - - -
  1. CP: Cyclophosphamide; MP: Methylprednisolone; OSt: Oral steroids; Cy: Cyclosporin; PEX: Plasma exchange
  2. NB: '+' represents a single course of cyclophosphamide in the Oral Cyclophosphamide column